XXII Stock Enjoys Slight Rise After New CEO Announcement
XXII stock enjoyed a slight rise on Tuesday after announcing Clifford B. Fleet as the Company's President and CEO. This follows on from 22nd Century Group (NYSE:XXII) hitting a 52-week low last week. Mr. Fleet previously held ... [Read]
Arcadia Biosciences Announces New Partnership: Legacy Ventures Hawaii
Arcadia Biosciences (NASDAQ:RKDA) stock rose 2.6% as the company announced on Tuesday a new joint strategic venture with Legacy Ventures Hawaii. This new venture, Archipelago Ventures, will see Arcadia combine its expertise and resources in ... [Read]
INSYQ Plunges Nearly 10% Despite FDA Approving New Drug Application
Insys Therapeutics (OTCPK:INSYQ) experienced a whirlwind in the past months, from witnessing a 48% drop in Q4 revenue and paying a $225 million settlement that sent INSY stock up 12% to jumping 240% after receiving ... [Read]
IGC Stock Pulls Back After Solid Run Up Past Two Weeks
IGC stock has been correcting since yesterday on profit-taking after rising as much as 150% since June 13. Stock Jumps After Big Announcement On June 14, India Globalization Capital Inc (NYSE:IGC) made a significant announcement ... [Read]
INSY Stock Jumps 240%: Gets “First Day” Motion After Chapter 11 Filing
Insys Therapeutics (NASDAQ:INSY) is back in the news this week, after agreeing last Friday to pay a $225 million settlement to resolve criminal investigations regarding its role in marketing opioids, an addictive painkiller. This week, ... [Read]
INSY Stock Rises 12% After Paying $225M to Settle Opioid Investigations
Trying times for Insys Therapeutics (NASDAQ:INSY) have finally come to an end—but at a price. On Friday, the opioid manufacturer said it has agreed to pay a whopping $225 million to settle criminal investigations. And ... [Read]
CBIS Stock Down 4%: New Member Joins Scientific Advisory Board
While other cannabis companies focus on acquisitions and entering different markets, Cannabis Science (OTCPK:CBIS) continues to develop its clinical trial teams. Earlier today, the US company announced that it has appointed an influential member of ... [Read]
GW Pharmaceuticals Shares Rising Fast on Positive Q1 Results
GW Pharmaceuticals (NASDAQ:GWPH) is on the climb after the company reported positive Q1 results and news regarding its famed drug Epidiolex. With shares on the move over the last 7 days, the company is now ... [Read]
TILT Stock Slumps 17% After Quarterly Results: Still One to Watch?
TILT stock is showing heavy selling pressure in Thursday's session after TILT Holdings (CSE:TILT) (OTCQB:SVVTF) posted Q4 and fiscal 2018 earnings report. Late Wednesday, the company released its audited financial statement as well as a ... [Read]
Green Growth Brands Stock Gains Momentum, Up 30% in 2 Weeks
Cannabis firm Green Growth Brands (CSE:GGB) (OTCQB:GGBXF) has been on a high streak lately as its stock climbed as much as 30% on the Canadian Securities Exchange since April 16. The sudden spike in the stock ... [Read]